
SRI receives FDA clearance to initiate high-dose naloxone clinical trial
New formulation aims to reduce overdose fatalities caused by fentanyl and other synthetic opioids MENLO PARK, CA, UNITED STATES, June 10, 2025 /EINPresswire.com/ -- SRI announced today that the U.S. Food and Drug Administration (FDA) authorized …